World Health Organization (WHO) will review the request of inclusion of the obesity drug ‘Saxenda’ on its Model List of Essential Medicines at the end of April 2023. WHO gathers the most important drugs on its Model List of Essential Medicines. The Model List of Essential Medicines is a recommendation of health systems worldwide and […]